Detalles de la búsqueda
1.
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
Immunity
; 54(2): 340-354.e6, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567252
2.
Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRI.
Eur Radiol
; 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460013
3.
In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV.
Transpl Int
; 37: 12720, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38655204
4.
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.
Clin Infect Dis
; 76(12): 2200-2202, 2023 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883586
5.
Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV.
PLoS Pathog
; 17(3): e1009385, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33647022
6.
Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients.
J Clin Immunol
; 42(3): 546-558, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34989946
7.
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV.
PLoS Pathog
; 16(7): e1008560, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32667948
8.
Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy.
Transfus Med Hemother
; 49(1): 30-43, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35221866
9.
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
Clin Infect Dis
; 73(11): 2000-2008, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134134
10.
Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling.
Cell Mol Life Sci
; 74(15): 2839-2850, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28378044
11.
Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report.
Ther Adv Neurol Disord
; 17: 17562864241253917, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38813521
12.
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
Front Immunol
; 14: 878953, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37033971
13.
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case Report.
Neurol Neuroimmunol Neuroinflamm
; 10(5)2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385737
14.
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors.
Front Immunol
; 14: 1219165, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37915564
15.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
J Clin Invest
; 133(12)2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37159273
16.
Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy.
Biology (Basel)
; 11(4)2022 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35453735
17.
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
PLoS One
; 17(11): e0276929, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322587
18.
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.
Front Bioeng Biotechnol
; 10: 867042, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35480981
19.
Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
Front Immunol
; 13: 1027122, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36405747
20.
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Front Med (Lausanne)
; 8: 770381, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34901085